Passage BIO, Inc. financial data

Symbol
PASG on Nasdaq
Location
Philadelphia, PA
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 03 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 278% % -54%
Debt-to-equity 124% % 170%
Return On Equity -135% % -72%
Return On Assets -60% % -12%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3,207,810 shares -95%
Common Stock, Shares, Outstanding 3,182,810 shares 0.67%
Entity Public Float $25,400,000 USD -48%
Common Stock, Value, Issued $6,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 3,172,870 shares 3.1%
Weighted Average Number of Shares Outstanding, Diluted 3,172,870 shares 3.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $23,276,000 USD -42%
General and Administrative Expense $19,875,000 USD -20%
Operating Income (Loss) $49,296,000 USD 30%
Net Income (Loss) Attributable to Parent $45,522,000 USD 30%
Earnings Per Share, Basic -14.35 USD/shares 32%
Earnings Per Share, Diluted -14.35 USD/shares 32%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $46,303,000 USD 23%
Assets, Current $47,762,000 USD -39%
Property, Plant and Equipment, Net $4,107,000 USD -56%
Operating Lease, Right-of-Use Asset $10,168,000 USD -26%
Other Assets, Noncurrent $244,000 USD -47%
Assets $62,281,000 USD -39%
Accounts Payable, Current $1,113,000 USD 50%
Employee-related Liabilities, Current $2,740,000 USD -38%
Contract with Customer, Liability, Current $13,750,000 USD 67%
Liabilities, Current $23,083,000 USD 19%
Deferred Income Tax Liabilities, Net $3,044,000 USD -32%
Operating Lease, Liability, Noncurrent $20,443,000 USD -6.2%
Liabilities $43,526,000 USD 5.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $8,000 USD
Retained Earnings (Accumulated Deficit) $704,757,000 USD -6.9%
Stockholders' Equity Attributable to Parent $18,755,000 USD -69%
Liabilities and Equity $62,281,000 USD -39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $13,847,000 USD 27%
Net Cash Provided by (Used in) Financing Activities $8,742,000 USD
Net Cash Provided by (Used in) Investing Activities $39,631,000 USD 57%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 3,182,810 shares 0.67%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $25,784,000 USD 71%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $46,303,000 USD 23%
Deferred Tax Assets, Valuation Allowance $222,752,000 USD 1.3%
Deferred Tax Assets, Gross $225,796,000 USD 0.68%
Operating Lease, Liability $24,010,000 USD -5.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $45,530,000 USD 30%
Lessee, Operating Lease, Liability, to be Paid $37,299,000 USD -9.4%
Property, Plant and Equipment, Gross $8,024,000 USD -58%
Operating Lease, Liability, Current $3,567,000 USD -3.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,863,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,757,000 USD -3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.097 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $13,289,000 USD -15%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,973,000 USD 2.8%
Deferred Tax Assets, Operating Loss Carryforwards $105,425,000 USD 11%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $4,085,000 USD 2.8%
Additional Paid in Capital $723,512,000 USD 0.42%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $728,000 USD -76%
Deferred Tax Assets, Net of Valuation Allowance $3,044,000 USD -32%
Share-based Payment Arrangement, Expense $3,001,000 USD -48%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%